HDAC11 and breast carcinoma: Correspondingly, depletion of HDAC11 in cell lines derived from colorectal, prostate, ovarian, and breast cancers resulted in cell death and reduction in metabolic activity, but when HDAC11 is depleted in normal cells, no effects on survival or metabolic activity are seen [107].